BG105581A - Heterocyclic carboxamide-containing thiurea inhibitor of herpes viruses containing phenylenediamine group - Google Patents

Heterocyclic carboxamide-containing thiurea inhibitor of herpes viruses containing phenylenediamine group

Info

Publication number
BG105581A
BG105581A BG105581A BG10558101A BG105581A BG 105581 A BG105581 A BG 105581A BG 105581 A BG105581 A BG 105581A BG 10558101 A BG10558101 A BG 10558101A BG 105581 A BG105581 A BG 105581A
Authority
BG
Bulgaria
Prior art keywords
carbon atoms
alkyl
hydrogen
heteroaryl
herpes viruses
Prior art date
Application number
BG105581A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jonathan BLOOM
Kevin CURRAN
Martin DIGRANDI
Russell DUSHIN
Thomas Jones
Stanley Lang
Adma ROSS
Eugene Terefenko
Bryan O'HARA
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Publication of BG105581A publication Critical patent/BG105581A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG105581A 1998-12-09 2001-06-08 Heterocyclic carboxamide-containing thiurea inhibitor of herpes viruses containing phenylenediamine group BG105581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20855998A 1998-12-09 1998-12-09
PCT/US1999/028842 WO2000034258A2 (fr) 1998-12-09 1999-12-06 Thio-urees a carboxamide heterocyclique inhibitrices des virus de l'herpes et contenant un groupe phenylenediamine

Publications (1)

Publication Number Publication Date
BG105581A true BG105581A (en) 2001-12-31

Family

ID=22775044

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105581A BG105581A (en) 1998-12-09 2001-06-08 Heterocyclic carboxamide-containing thiurea inhibitor of herpes viruses containing phenylenediamine group

Country Status (18)

Country Link
EP (1) EP1144397A3 (fr)
JP (1) JP2002531554A (fr)
CN (1) CN1348446A (fr)
AU (1) AU1934700A (fr)
BG (1) BG105581A (fr)
BR (1) BR9916046A (fr)
CA (1) CA2350767A1 (fr)
CZ (1) CZ20011956A3 (fr)
EA (1) EA200100631A1 (fr)
HU (1) HUP0200232A2 (fr)
ID (1) ID30158A (fr)
IL (1) IL143182A0 (fr)
NO (1) NO20012832L (fr)
PL (1) PL349217A1 (fr)
SK (1) SK7682001A3 (fr)
TR (1) TR200101664T2 (fr)
WO (1) WO2000034258A2 (fr)
ZA (1) ZA200104377B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
DK1259485T3 (da) 2000-02-29 2006-04-10 Millennium Pharm Inc Benzamider og beslægtede inhibitorer for faktor Xa
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
ES2382055T3 (es) 2006-11-02 2012-06-04 Millennium Pharmaceuticals, Inc. Métodos para sintetizar sales farmacéuticas de un inhibidor del factor Xa
WO2014070979A1 (fr) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibiteurs de cytomégalovirus
EP2914591B1 (fr) * 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibiteurs de cytomégalovirus
CN110565100B (zh) * 2019-07-12 2021-05-07 西北工业大学 一种二茂钴阳离子基缓蚀剂及制备方法和使用方法
CN117769548A (zh) 2021-08-05 2024-03-26 浙江海正药业股份有限公司 芳香乙炔类衍生物及其制备方法和用途
WO2023088718A1 (fr) 2021-11-19 2023-05-25 Basf Se Composés bicycliques pour la lutte contre les nuisibles invertébrés
CN115433093A (zh) * 2022-09-26 2022-12-06 无锡双启科技有限公司 一种3-氯-4-三氟甲基苯胺的制备方法
CN115710190A (zh) * 2022-11-16 2023-02-24 常州佳德医药科技有限公司 4-甲氧基-2-氨基-n,n-二甲基苯胺、制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69811062T2 (de) * 1997-04-10 2003-07-17 Upjohn Co Polyaromatische antivirale zusammensetzungen

Also Published As

Publication number Publication date
AU1934700A (en) 2000-06-26
CN1348446A (zh) 2002-05-08
PL349217A1 (en) 2002-07-01
EP1144397A3 (fr) 2002-09-11
ZA200104377B (en) 2002-12-20
ID30158A (id) 2001-11-08
NO20012832D0 (no) 2001-06-08
SK7682001A3 (en) 2002-07-02
EP1144397A2 (fr) 2001-10-17
CA2350767A1 (fr) 2000-06-15
IL143182A0 (en) 2002-04-21
BR9916046A (pt) 2001-10-02
NO20012832L (no) 2001-08-07
EA200100631A1 (ru) 2002-02-28
CZ20011956A3 (cs) 2001-10-17
JP2002531554A (ja) 2002-09-24
WO2000034258A2 (fr) 2000-06-15
HUP0200232A2 (hu) 2002-05-29
TR200101664T2 (tr) 2002-03-21
WO2000034258A3 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
BG105581A (en) Heterocyclic carboxamide-containing thiurea inhibitor of herpes viruses containing phenylenediamine group
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
WO2000034237A3 (fr) Inhibiteurs des virus de l'herpes a base de thio-urees contenant des acetamides et des acetamides substitues
IL106473A0 (en) Acetylene derivatives and crop protection agents containing them
BG105583A (en) Thiourea as inhibitor of herpes viruses
EA200100639A1 (ru) Производные тиомочевины, содержащие гетероциклический карбоксамид и защитную группу фенилэтиленамина, в качестве ингибиторов вирусов герпеса
WO2000034260A3 (fr) THIO-UREES α-METHYLBENZYLEES PORTEUSES D'UN GROUPE PHENYLENE-DIAMINE ET INHIBITRICES DES VIRUS DE L'HERPES
DK0383686T3 (da) Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf
CS108985A2 (en) Zpusob vyroby novych derivatu 3 fenyl 2 propenaminu
EA200100635A1 (ru) Производные тиомочевины в качестве ингибиторов вирусов герпеса
PT1021405E (pt) Derivados de azetidinona para o tratamento de infeccoes de hcmv
EA200100637A1 (ru) Ингибиторы вирусов герпеса на основе тиомочевины
PL337226A1 (en) Fungicidal mixtures
ES479110A1 (es) Procedimiento para preparar derivados de benzamidina.
ES2031594T3 (es) Tioeteres aromaticos.
DE3271277D1 (en) Tropyl and pseudotropyl alkyl-benzoates and their use in migraine treatment
GR880100112A (en) Method of preparation of new acetamide deravatives of dihydro-2,3 phenyl-3 benzophouranone-2
EP0443474A3 (en) 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents